153 related articles for article (PubMed ID: 33296976)
1. Ventral posterior nucleus volume is associated with neuropathic pain intensity in neuromyelitis optica spectrum disorders.
Asseyer S; Kuchling J; Gaetano L; Komnenić D; Siebert N; Chien C; Scheel M; Oertel FC; Ruprecht K; Bellmann-Strobl J; Finke C; Chakravarty MM; Magon S; Wuerfel J; Paul F; Papadopoulou A; Brandt AU
Mult Scler Relat Disord; 2020 Nov; 46():102579. PubMed ID: 33296976
[TBL] [Abstract][Full Text] [Related]
2. Attack-related damage of thalamic nuclei in neuromyelitis optica spectrum disorders.
Papadopoulou A; Oertel FC; Gaetano L; Kuchling J; Zimmermann H; Chien C; Siebert N; Asseyer S; Bellmann-Strobl J; Ruprecht K; Chakravarty MM; Scheel M; Magon S; Wuerfel J; Paul F; Brandt AU
J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1156-1164. PubMed ID: 31127016
[TBL] [Abstract][Full Text] [Related]
3. The risk factors of neuropathic pain in neuromyelitis optica spectrum disorder: a retrospective case-cohort study.
Li X; Xu H; Zheng Z; Ouyang H; Chen G; Lou Z; Chen H; Zhang J; Zhan Y; Mao H; Zhang C; Zhao M; Zhao Y
BMC Neurol; 2022 Aug; 22(1):304. PubMed ID: 35986246
[TBL] [Abstract][Full Text] [Related]
4. Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis.
Tackley G; Vecchio D; Hamid S; Jurynczyk M; Kong Y; Gore R; Mutch K; Woodhall M; Waters P; Vincent A; Leite MI; Tracey I; Jacob A; Palace J
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):165-169. PubMed ID: 27884934
[TBL] [Abstract][Full Text] [Related]
5. Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity.
Chien C; Scheel M; Schmitz-Hübsch T; Borisow N; Ruprecht K; Bellmann-Strobl J; Paul F; Brandt AU
Mult Scler; 2019 Dec; 25(14):1926-1936. PubMed ID: 30475082
[TBL] [Abstract][Full Text] [Related]
6. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
7. Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders.
Asseyer S; Schmidt F; Chien C; Scheel M; Ruprecht K; Bellmann-Strobl J; Brandt AU; Paul F
Mult Scler J Exp Transl Clin; 2018; 4(3):2055217318796684. PubMed ID: 30186620
[TBL] [Abstract][Full Text] [Related]
8. Regional spinal cord volumes and pain profiles in AQP4-IgG + NMOSD and MOGAD.
Asseyer S; Zmira O; Busse L; Pflantzer B; Schindler P; Schmitz-Hübsch T; Paul F; Chien C
Front Neurol; 2024; 15():1308498. PubMed ID: 38343712
[TBL] [Abstract][Full Text] [Related]
9. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
10. Brain changes correlate with neuropathic pain in patients with neuromyelitis optica spectrum disorders.
Chen H; Lian Z; Liu J; Shi Z; Du Q; Feng H; Zhang Q; Yang M; Wu X; Zhou H
Mult Scler Relat Disord; 2021 Aug; 53():103048. PubMed ID: 34090129
[TBL] [Abstract][Full Text] [Related]
11. Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive Patients.
Ayzenberg I; Richter D; Henke E; Asseyer S; Paul F; Trebst C; Hümmert MW; Havla J; Kümpfel T; Ringelstein M; Aktas O; Wildemann B; Jarius S; Häußler V; Stellmann JP; Senel M; Klotz L; Pellkofer HL; Weber MS; Pawlitzki M; Rommer PS; Berthele A; Wernecke KD; Hellwig K; Gold R; Kleiter I;
Neurol Neuroimmunol Neuroinflamm; 2021 May; 8(3):. PubMed ID: 34108267
[TBL] [Abstract][Full Text] [Related]
12. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
[TBL] [Abstract][Full Text] [Related]
13. Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders.
Zalewski NL; Morris PP; Weinshenker BG; Lucchinetti CF; Guo Y; Pittock SJ; Krecke KN; Kaufmann TJ; Wingerchuk DM; Kumar N; Flanagan EP
J Neurol Neurosurg Psychiatry; 2017 Mar; 88(3):218-225. PubMed ID: 27913626
[TBL] [Abstract][Full Text] [Related]
14. Anti-AQP4 autoantibodies promote ATP release from astrocytes and induce mechanical pain in rats.
Ishikura T; Kinoshita M; Shimizu M; Yasumizu Y; Motooka D; Okuzaki D; Yamashita K; Murata H; Beppu S; Koda T; Tada S; Shiraishi N; Sugiyama Y; Miyamoto K; Kusunoki S; Sugimoto T; Kumanogoh A; Okuno T; Mochizuki H
J Neuroinflammation; 2021 Aug; 18(1):181. PubMed ID: 34419102
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of bright spotty lesions on MRI after a first episode of acute myelopathy.
Rabasté S; Cobo-Calvo A; Nistiriuc-Muntean V; Vukusic S; Marignier R; Cotton F;
J Neuroradiol; 2021 Feb; 48(1):28-36. PubMed ID: 32407908
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
[TBL] [Abstract][Full Text] [Related]
18. Application of the 2015 neuromyelitis optica spectrum disorders diagnostic criteria in a cohort of Chinese patients.
He M; Wu L; Huang D; Yu S
Mult Scler Relat Disord; 2020 Nov; 46():102459. PubMed ID: 32853894
[TBL] [Abstract][Full Text] [Related]
19. [Actual issues of serum aquaporin-4 autoantibodies evaluation in the diagnostics of neuromyelitis optica spectrum disorders].
Krasnov VS; Totolyan NA; Nazarov VD; Mazing AV; Makshakov GS; Lapin SV; Evdoshenko EP; Skoromets AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7. Vyp. 2):24-31. PubMed ID: 32844626
[TBL] [Abstract][Full Text] [Related]
20. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
